SEC Form 4 · accession 0001209191-18-060310
ImmunityBio, Inc. · IBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Gorlin
Director
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 7:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326110
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 27, 2018 | S | 100,000 | $1.752 | D | 189,508 | I | By spouse |
| Common StockF2 | Nov 28, 2018 | S | 17,140 | $1.7576 | D | 172,368 | I | By spouse |
| Common StockF3 | Nov 29, 2018 | S | 34,019 | $1.6986 | D | 138,349 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average share price of an aggregate total of 100,000 shares sold in the price range of $1.75 to $1.7768 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Represents the weighted average share price of an aggregate total of 17,140 shares sold in the price range of $1.75 to $1.78 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Represents the weighted average share price of an aggregate total of 34,019 shares sold in the price range of $1.659 to $1.705 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.